Zobrazeno 1 - 10
of 14
pro vyhledávání: '"January M. Watters"'
Autor:
Eric B. Haura, Uwe Rix, Yian Ann Chen, Kate Fisher, Jamie K. Teer, John M. Koomen, Lanxi Song, Fumi Kinose, Bin Fang, January M. Watters, Jae-Young Kim, Yun Bai
Supplementary Methods. Description of additional methods and procedures used in the study.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0aeda1cc841be685536403f9b5f149a0
https://doi.org/10.1158/0008-5472.22405002.v1
https://doi.org/10.1158/0008-5472.22405002.v1
Autor:
Eric B. Haura, Uwe Rix, Yian Ann Chen, Kate Fisher, Jamie K. Teer, John M. Koomen, Lanxi Song, Fumi Kinose, Bin Fang, January M. Watters, Jae-Young Kim, Yun Bai
Supplementary Table S5. Bliss analysis summary of drug combinations with dasatinib in DDR2-mutant squamous cell carcinoma cells.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37fbfde43b37d38a1aa66175f22a68e9
https://doi.org/10.1158/0008-5472.22404987.v1
https://doi.org/10.1158/0008-5472.22404987.v1
Autor:
Eric B. Haura, Uwe Rix, Yian Ann Chen, Kate Fisher, Jamie K. Teer, John M. Koomen, Lanxi Song, Fumi Kinose, Bin Fang, January M. Watters, Jae-Young Kim, Yun Bai
Supplementary Figures S1-S5. Quantification of Western blotting bands (S1); LC-MRM analysis of IGF-1R and EGFR tyrosine phosphorylation (S2); Validation of drug effect (S3); Dasatinib-based drug combinations in DDR2-mutant squamous cell lung carcinom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::631a228f0c8cf0b70fe47224a03a23a2
https://doi.org/10.1158/0008-5472.22405005.v1
https://doi.org/10.1158/0008-5472.22405005.v1
Autor:
Eric B. Haura, Uwe Rix, Yian Ann Chen, Kate Fisher, Jamie K. Teer, John M. Koomen, Lanxi Song, Fumi Kinose, Bin Fang, January M. Watters, Jae-Young Kim, Yun Bai
Supplementary Table S3. Dasatinib-regulated pY-peptides identified from both cell lines (n=73).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::929cbee6c15486c8eca5046142b88ff6
https://doi.org/10.1158/0008-5472.22404993.v1
https://doi.org/10.1158/0008-5472.22404993.v1
Autor:
Eric B. Haura, Uwe Rix, Yian Ann Chen, Kate Fisher, Jamie K. Teer, John M. Koomen, Lanxi Song, Fumi Kinose, Bin Fang, January M. Watters, Jae-Young Kim, Yun Bai
Supplementary Figure and Table Legends. Legend for Supplementary Figures S1-S5 and Supplementary Tables S1-S5.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5e92f4ea715b4385e34fdb572417449
https://doi.org/10.1158/0008-5472.22405008.v1
https://doi.org/10.1158/0008-5472.22405008.v1
Autor:
Eric B. Haura, Uwe Rix, Yian Ann Chen, Kate Fisher, Jamie K. Teer, John M. Koomen, Lanxi Song, Fumi Kinose, Bin Fang, January M. Watters, Jae-Young Kim, Yun Bai
Supplementary Table S2. Dasatinib-regulated pY peptides after QC and storey q-value
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0f3b5495b8214e2f548c95c1f121490
https://doi.org/10.1158/0008-5472.22404996.v1
https://doi.org/10.1158/0008-5472.22404996.v1
Autor:
Eric B. Haura, Uwe Rix, Yian Ann Chen, Kate Fisher, Jamie K. Teer, John M. Koomen, Lanxi Song, Fumi Kinose, Bin Fang, January M. Watters, Jae-Young Kim, Yun Bai
Supplementary Table S1. pY peptides identified by phosphoproteomics in two DDR2 mutation cell line treated with or without 500 nM dasatinib for 3 hour (543, 636 pY peptides in H2286 and HCC366, respectively).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad36081d972b557d6004f9147d099e15
https://doi.org/10.1158/0008-5472.22404999.v1
https://doi.org/10.1158/0008-5472.22404999.v1
Autor:
Eric B. Haura, Uwe Rix, Yian Ann Chen, Kate Fisher, Jamie K. Teer, John M. Koomen, Lanxi Song, Fumi Kinose, Bin Fang, January M. Watters, Jae-Young Kim, Yun Bai
Supplementary Table S4. Raw heatmap excel spread sheet file for Fig. 4A.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b8f297af1e40578019da6c8e4f57814
https://doi.org/10.1158/0008-5472.22404990
https://doi.org/10.1158/0008-5472.22404990
Publikováno v:
Biochem Biophys Res Commun
Mantle Cell Lymphoma (MCL) is a non-Hodgkin lymphoma with a median survival rate of five years. Standard treatment with high-dose chemotherapy plus rituximab (anti-CD20 antibody) has extended overall survival although, the disease remains incurable.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2acef502ac526a48ab8fa1b5fef63720
https://pubmed.ncbi.nlm.nih.gov/33190829
https://pubmed.ncbi.nlm.nih.gov/33190829
Autor:
Jessica A. Reusch, January M. Watters, Katerina Vrzalikova, Michelle Maurin, Lou-Ella M.M. Alexander, Paul Murray, Kenneth L. Wright, Mark G. Alexandrow, Brook S. Nepon-Sixt
Publikováno v:
Molecular Immunology. 91:8-16
B cell activation is dependent on a large increase in transcriptional output followed by focused expression on secreted immunoglobulin as the cell transitions to an antibody producing plasma cell. The rapid transcriptional induction is facilitated by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49512ceec8d463f757aac995f0ba2eb1
https://doi.org/10.1016/j.molimm.2017.08.016
https://doi.org/10.1016/j.molimm.2017.08.016